Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across cancer, cardiovascular disease and inflammation

          Learn more

        • Cancer
        • Inflammation
        • Cardiovascular
        • Programs
        • Laboratories
        • Diseases
        • Expertises
        • Services and instrumentation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your will
        • Donate in Memory
  • Impact
        • Impact

          Our research develops new diagnostics, treatments and cures for some of the most deadly and debilitating diseases affecting society today

          Learn more

        • Breakthroughs
        • Community and research
  • Careers & studies
        • Careers & Studies

          Take the next step in your career with Centenary, Australia’s foremost clinically integrated medical research institute

          Learn more

        • Career opportunities
        • Life at Centenary
        • Post-Doctorate Research
        • PhD
        • Masters
        • Honours
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events

        • News
        • Events
        • Media Hub
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Our researchers
        • Contact
  • Donate
    Centenary Institute > Research > Inflammation

Inflammation

Increasingly found to play crucial roles in the development of most major diseases, including Alzheimer’s, heart disease, cancer, respiratory diseases, diabetes, and tuberculosis.

Why inflammation is the key

Our belief is that understanding inflammation is the key to unlocking a new era of treatments and cures for many of the deadliest and prominent diseases effecting humanity. The Centenary Institute is at the forefront of this life-saving medical research. We are driven to understand the role of inflammation and the immune system how this drives the disease processes.

As a fundamental mechanism by which the body’s immune system reacts to injury, inflammation is critical in resolving infection or trauma. However, it also underlies a number of prevalent acute and chronic conditions, such as allergies and autoimmune diseases, and drives the initiation and progression of cancer and cardiovascular disease.

By placing inflammation research at the centre of our goals of understanding, we are seeking ways to heal inflammatory conditions (autoimmunity, allergy), cancer and cardiovascular diseases. We continue to study the chief cellular components of inflammation, the blood white cells and the lining of blood vessels and how they react to injury. Our research has defined new mechanisms and devised new drug candidates.

Our research programs and laboratories investigating inflammation

  • Centenary UTS Centre for Inflammation

    Inflammation is increasingly being found to play crucial roles in the development of many major diseases, i­ncluding Alzheimer’s, heart disease, cancer, respiratory diseases, diabetes, tuberculosis and COVID-19. The Centenary UTS Centre for Inflammation (CFI) is Australia’s first research centre dedicated exclusively to studying the mechanisms underlying inflammation, to understand how specific diseases develop and progress and can be treated.
  • Liver Enzymes in Metabolism and Inflammation Program

    The ongoing increase in all forms of liver disease is a large burden for our healthcare system. Especially the 350% increase in liver cancer in the last 30 years. Much of this increase is attributed to metabolic disease, often in conjunction with diabetes. Our focus in liver disease research is understanding the roles of a key enzyme family in progressive liver damage and cancer.
  • Tuberculosis Research Program

    Worldwide, Tuberculosis (TB) is the 13th leading cause of death and the second leading infectious killer after COVID-19.
    Prof Warwick Britton
  • Alcoholic Liver Disease

    The Alcoholic Liver Disease research program includes studies on genetics of alcoholic cirrhosis and molecular mechanisms underlying liver disease. By identifying biomarkers for alcohol use and liver injury, we utilise transcriptomics, lipid and miRNA profiling to find treatment targets and pathways.

Achievements

  • Researchers find new target to combat lung disease

    Research led by the Centenary Institute and University of Technology Sydney has identified a small RNA molecule called microRNA-21 as a therapeutic target and its inhibition as a potential treatment for chronic obstructive pulmonary disease (COPD).
    Read more
  • Genetic risk test developed to predict alcohol-related cirrhosis of the liver

    An international research group led by the Centenary Institute has developed a world first genetic risk score (GRS) test able to identify patients at high-risk of developing alcohol-related cirrhosis.
    Read more

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About
  • Governance
  • Corporate information

Research

  • Programs
  • Laboratories
  • Our researchers
  • News
  • Media hub

Careers & studies

  • Career opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram